IP Australia’s latest patent statistics covering January through November 2025 show some interesting patterns in what Australians are inventing and protecting. Total patent applications reached approximately 28,400, down 3.2% from 2024’s pace. That modest decline masks significant variation across different technology categories.

AI and machine learning patents decreased noticeably—down 18% compared to 2024. That reverses several years of strong growth. Whether this reflects market saturation, decreased venture funding for AI startups, or a strategic shift away from patent protection toward trade secrets is unclear. Probably all three factors contribute.

Medical device patents remained stable, continuing their position as Australia’s strongest patent category by volume. The country has genuine capability in medical technology innovation, and patent filings reflect actual commercial activity rather than speculative protection. Around 3,800 medical device applications were filed, consistent with recent years.

Agricultural technology patents increased 12%, driven particularly by drought-resistant crop varieties and precision agriculture technologies. Climate adaptation is forcing innovation in Australian agriculture, and the patent data shows that transition happening in real time. Whether these innovations will commercialize successfully is a separate question.

The foreign applicant versus domestic applicant split remained at roughly 90% foreign, 10% domestic. That ratio has been stable for years and reflects Australia’s role as a market for foreign technology rather than a major innovation producer. It’s not an encouraging statistic for those hoping to build an innovation economy.

Chinese entities continued increasing their Australian patent filings, now representing approximately 35% of foreign applications. US entities account for 28%, down from 35% five years ago. The shifting balance reflects China’s growing technological capabilities and interest in protecting IP in Australian markets.

Universities filed about 420 patent applications, marginally down from 2024. That number seems low given the volume of research occurring, but reflects the reality that most academic research isn’t commercially viable enough to justify patent costs. The universities that do file patents tend to be the same institutions year after year—UNSW, University of Sydney, University of Melbourne, and Monash dominate academic patents.

Individual inventor applications dropped to around 1,200, continuing a long-term declining trend. The independent inventor working in their garage or home workshop is becoming rarer, or at least less likely to pursue patent protection. Rising patent costs and the complexity of the patent system probably discourage individual applicants.

Software patent applications require special mention because they exist in legal grey area. Australian patent law theoretically requires patents to protect physical processes or products, not pure software or business methods. In practice, clever claim drafting can secure protection for software-implemented inventions. About 4,700 applications fell into this category, down from 5,200 in 2024.

The examination backlog at IP Australia has worsened slightly. Average time from application to first examination now sits around 16 months, up from 14 months last year. Budget constraints limited IP Australia’s ability to hire additional examiners despite increasing workload. That delay creates uncertainty for applicants and can affect investment decisions waiting on patent status.

Patent maintenance data is revealing. Approximately 23% of granted patents are abandoned before their full 20-year term, usually due to maintenance fee nonpayment. That suggests considerable over-patenting—applicants protecting inventions that ultimately don’t justify the ongoing costs. The technology sector shows highest abandonment rates, while pharmaceutical patents are rarely abandoned.

The cost barrier remains significant. Filing a patent application costs $400-600 in official fees, but the real expense comes from patent attorney fees for drafting and prosecution, typically $8,000-15,000 for a basic application. International filings multiply costs substantially. That excludes most individual inventors and small startups from patent protection unless they secure external funding.

Provisional patent applications numbered around 4,100, used by applicants to establish priority dates while continuing development work. Many provisionals are never converted to complete applications, either because the technology doesn’t progress or because applicants decide patent protection isn’t worthwhile. That’s a sensible filtering mechanism that prevents premature commitment to patent prosecution.

Design patents showed modest growth at 6%, reaching about 1,850 applications. These protect aesthetic rather than functional aspects of products and are popular for consumer goods. The process is faster and cheaper than utility patents, making it more accessible for designers and small manufacturers.

The gender gap in patent applications remains stubbornly persistent. Only 17% of patent applications included at least one female inventor, unchanged from previous years despite various diversity initiatives. The gap reflects underlying STEM participation disparities that patent policy alone cannot address.

Patent litigation remains relatively rare in Australia compared to the US. Only 78 patent infringement cases were filed in federal courts through November, and most settled before trial. The legal costs of patent litigation discourage speculative lawsuits, which creates a different environment than US patent troll culture. That’s probably good for genuine innovation.

The pharmaceutical patent landscape is dominated by large international companies protecting drug formulations and medical treatments. Australia’s Pharmaceutical Benefits Scheme creates unique dynamics where patent status directly affects government reimbursement decisions. That makes Australian pharmaceutical patents particularly strategic despite the relatively small market size.

Emerging technology categories show interesting patterns. Quantum computing patents increased from basically zero three years ago to about 30 applications in 2025. That’s tiny in absolute terms but represents 100% growth year-over-year. Whether quantum computing delivers on its promise or becomes another overhyped technology remains to be seen.

The effectiveness of patents in actually protecting innovation is debatable. Large companies with legal resources can often design around patents or intimidate smaller competitors into settlements. Small companies and individual inventors lack resources to enforce patent rights against well-funded infringers. The system works better for established players than disruptors.

For Australian innovation policy, the patent data suggests we’re consumers of foreign technology protected via Australian patents rather than generators of technology exported elsewhere. That’s economically sustainable—countries don’t need to invent everything locally—but does raise questions about capturing value from innovation versus just providing markets for foreign IP.

The 2025 numbers will finalize early next year once late applications are processed. The trends are clear enough though: modest overall decline, significant sectoral variation, and continued dominance by foreign applicants. Whether that represents success or failure depends entirely on what you think Australia’s innovation system should achieve.